BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 3:23:00 PM | Browse: 936 | Download: 780
Publication Name World Journal of Radiology
Manuscript ID 8707
Country/Territory United States
Received
2014-01-03 16:10
Peer-Review Started
2014-01-03 21:03
To Make the First Decision
2014-01-23 17:10
Return for Revision
2014-02-09 21:10
Revised
2014-02-16 12:19
Second Decision
2014-03-14 18:22
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-14 18:35
Articles in Press
2014-05-23 12:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-06-20 11:23
Publish the Manuscript Online
2014-06-28 15:27
ISSN 1949-8470 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Radiology, Nuclear Medicine & Medical Imaging
Manuscript Type Topic Highlights
Article Title Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers
Manuscript Source Invited Manuscript
All Author List Farzan Siddiqui and Min Yao
Funding Agency and Grant Number
Corresponding Author Min Yao, MD, PhD, Department of Radiation Oncology, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, OH 44106, United States. min.yao@uhhospitals.org
Key Words Fluorodeoxyglucose; Positron emission tomography; Squamous cell carcinoma; Head and neck cancer; Radiation therapy planning
Core Tip Fluorodeoxyglucose positron emission tomography (FDG PET) computed tomography (CT) scans should be obtained for patients for squamous cell carcinoma of the head and neck whenever clinically indicated and feasible. Pre-treatment scans are helpful in detecting the sites of primary cancer, staging the tumor and ruling out the presence of distant metastases. For patients undergoing radiation therapy, PET/CT scans provide anatomic as well as functional information to aid in treatment planning. After completion of radiotherapy, PET scans should be obtained approximately 12 wk after treatment to assess treatment response and to determine if any salvage therapy is required for persistent, recurrent or metastatic disease.
Publish Date 2014-06-28 15:27
Citation Siddiqui F, Yao M. Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers. World J Radiol 2014; 6(6): 238-251
URL http://www.wjgnet.com/1949-8470/full/v6/i6/238.htm
DOI http://dx.doi.org/10.4329/wjr.v6.i6.238
Full Article (PDF) WJR-6-238.pdf
Full Article (Word) WJR-6-238.doc
Manuscript File 8707-Review.docx
Answering Reviewers 8707-Answering reviewers.pdf
Copyright License Agreement 8707-Copyright assignment.pdf
Peer-review Report 8707-Peer review(s).pdf
Scientific Editor Work List 8707-Scientific editor work list.doc